LSJ | Pluvicto | VA Phoenix Healthcare System
Awarded Limited / Sole Source Justification Posted
See the award notice from .
- Solicitation number
- 36C262-26-AP-0681
- Agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79720D0180-36C26226F0048 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Arizona 85012, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA Phoenix Healthcare System) issued this Limited Source Justification Notice on January 8, 2026, for the procurement of Pluvicto, a specialized radiopharmaceutical used to treat metastatic castration-resistant prostate cancer. The justification for sole-source procurement is based on Pluvicto being the first and only FDA-approved targeted radioligand therapy for this specific cancer indication, with no therapeutically equivalent alternatives currently available in the United States. Novartis Pharmaceuticals Corporation was awarded the delivery order under the VA National Acquisition Center Pharmaceutical Catalog on January 2, 2026, with no competing bids received following a special notice posted on SAM.gov in October 2025. The contract covers 30 doses per year at $33,229.14 per dose, with a total estimated value of $4,984,371.00 over a five-year period from January 1, 2026, through December 31, 2030, consisting of a base year plus four option years. The VA NAC verified the pricing as fair and reasonable prior to award under the Multiple-Award Schedule Program.
Notice text
See attached Limited Sources Justification (LSJ)
Awarded contract 36F79720D0180 to unknown vendor for unknown amount on 2026-01-02.
Files
| File | Type | Posted |
|---|---|---|
| LSJ.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pluvicto | VA Phoenix Healthcare System | Award Notice | |
| This notice | Limited / Sole Source Justification | |
| 6505--PLUVICTO | LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML VA Phoenix Healthcare System | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--VA Long Beach Pylarify | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity